Brazilian regulators nix plan to inspect foreign plants; Bausch and Lomb recalls eye treatment;

> Bausch and Lomb is recalling some of its 27G disposable sterile cannula that are provided with Amvisc and Amvisc Plus Ophthalmic Viscosurgical Devices because they may leak viscoelastic material or detach from the syringe during injection, sometimes causing serious patient injury. FDA release

> Adaptimmune has a cell therapy manufacturing services agreement with NeoStem and its subsidiary, Progenitor Cell Therapy (PCT), for PCT to provide cell product development and manufacturing for Adaptimmune's clinical trials for Adaptimmune's NYESO-1 c259-T cell therapy product being developed for oncology indications. Release

> The Recipharm International Environmental Award 2012 has been awarded to Dr. Damià Barceló, director of the Catalan Institute for Water Research (ICRA) and research professor at the Institute of Environmental Assessment and Water Studies, for his work to shift the scientific community's focus toward tackling emerging pollutants. Release

> Anvisa, Brazil's national regulatory agency, has given up plans to try to conduct its own inspections of foreign manufacturing plants. Item

> Watson Pharmaceuticals ($WPI) has picked up even more manufacturing capacity in its $305 million acquisition of the Belgium-based Uteron Pharma. Item

And Finally... A new report says that while the barriers to entry are high for vaccine manufacturing, there will be chances for contract manufacturers to tap that growing market over the next decade. Story